急性缺血性卒中患者凝血酶生成与白细胞炎症谱的关联
本研究从急性缺血性卒中患者全血中分离RNA,分析凝血酶生成能力与白细胞基因表达的关系,排除使用抗凝药者。在97例患者中,峰值凝血酶范围为252.0至752.4 nM,其升高与血栓炎症白细胞基因表达差异相关,涉及白介素6、凝血酶和NF-κB信号通路;基于免疫激活的线性判别分析模型可在另一112例患者队列中区分低与高峰值凝血酶。
要点
- 急性缺血性卒中患者峰值凝血酶范围252.0至752.4 nM,个体间变异明显。
- 峰值凝血酶升高与ADAMTS13表达降低及NF-κB激活蛋白、PDIA5、TFPI2表达升高相关。
- 相关通路包括白介素6信号、凝血酶信号和NF-κB信号。
核心结论
- 所识别的基因和通路支持免疫系统参与卒中患者血栓形成,可能与卒中预防的抗血栓策略相关。
研究设计与样本
- 研究从急性缺血性卒中患者全血中分离RNA,排除使用抗凝药者,采用协方差分析按峰值凝血酶四分位分组并校正性别和年龄,评估基因表达与峰值凝血酶的关系。
- 研究纳入97例急性缺血性卒中患者,并在另一112例急性缺血性卒中患者队列中验证线性判别分析模型。
主要发现
- 在97例急性缺血性卒中患者中,峰值凝血酶范围为252.0至752.4 nM。
- 峰值凝血酶升高与血栓炎症白细胞基因表达差异相关,包括ADAM金属肽酶含血小板反应蛋白1型基序13表达降低,以及核因子κB激活蛋白、蛋白质二硫键异构酶家族A成员5和組織因子途径抑制物2表达升高。
- 与峰值凝血酶相关的通路包括白介素6信号、凝血酶信号和NF-κB信号。
- 线性判别分析模型总结第一队列卒中患者中与峰值凝血酶相关的免疫激活,可在第二队列112例急性缺血性卒中患者中区分低峰值凝血酶与高峰值凝血酶患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Thrombosis is central to the pathogenesis of acute ischemic stroke, with higher thrombin generation being associated with increased stroke risk. The immune system may contribute to thrombin generation in stroke and thus may offer novel strategies for stroke prevention. This study addresses the research question regarding the relationship of thrombin generation to leukocyte gene expression in patients with acute ischemic stroke. METHODS: We isolated RNA from whole blood and examined the relationship to thrombin generation capacity in patients with acute ischemic stroke. Due to its effects on thrombin generation, patients on anticoagulants were excluded from the study. The relationship of gene expression with peak thrombin was evaluated by analysis of covariance across peak thrombin quartiles adjusted for sex and age. RESULTS: In 97 patients with acute ischemic stroke, peak thrombin was variable, ranging from 252.0 to 752.4 nM. Increased peak thrombin was associated with differences in thromboinflammatory leukocyte gene expression, including a decrease in ADAM metallopeptidase with thrombospondin type 1 motif 13 and an increase in nuclear factor κB (NF-κB)-activating protein, protein disulfide isomerase family A member 5, and tissue factor pathway inhibitor 2. Pathways associated with peak thrombin included interleukin 6 signaling, thrombin signaling, and NF-κB signaling. A linear discriminant analysis model summarizing the immune activation associated with peak thrombin in a first cohort of stroke could distinguish patients with low peak thrombin from high peak thrombin in a second cohort of 112 patients with acute ischemic stroke. DISCUSSION: The identified genes and pathways support a role of the immune system contributing to thrombus formation in patients with stroke. These may have relevance to antithrombotic strategies for stroke prevention.
引用
- Falcione S, Munsterman D, Joy T, et al. Association of Thrombin Generation With Leukocyte Inflammatory Profile in Patients With Acute Ischemic Stroke. Neurology. 2022. PMID: 35790427. doi:10.1212/WNL.0000000000200909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。